Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression.

Some men may be candidates for more prolonged PSA testing intervals. High PSA and short PSA double time are associated with a greater likelihood of a positive bone scan. PSA levels and kinetics ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels. Persistently elevated PSA levels indicate residual cancer and are linked ...

The rate at which PSA rises after hormonal therapy for prostate cancer is a key factor in determining the effectiveness of the treatment.

On average, men's levels of prostate-specific antigen (PSA) decrease as their body mass index (BMI) rises, a new study shows.

A new urine test could help men with an elevated PSA, or prostate specific antigen, level avoid unnecessary biopsies and MRIs. The test screens for 18 genetic markers in the urine that are highly ...

Two of the most commonly used classes of medication—statins and nonsteroidal anti-inflammatory drugs (NSAIDs)—may compromise already controversial cancer screenings by lowering serum levels of ...

Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with non-metastatic ...

“Checking the PSA level too soon can lead clinicians to mislabel a patient as having recurred and prompt referral to radiation and medical oncologists to initiate salvage radiation and hormonal ...